The new upgrade programme enables hospitals using select Innova and Discovery image-guided systems to access AI-powered imaging and workflow technologies from the Allia platform while extending equipment life and minimising operational disruption.
The proposed joint venture will accelerate the launch of pharmaceutical and consumer healthcare products across South-East Asia, the Middle East, Africa, and other emerging markets
Digital platform aims to expand access to palliative care through teleconsultations, training, community engagement and global knowledge-sharing
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
TB Alliance will continue to lead clinical development, while Lupin will leverage its global manufacturing, regulatory, and supply chain expertise to ensure the drug reaches patients worldwide
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
Subscribe To Our Newsletter & Stay Updated
